InnovAge Holding Corp
NASDAQ:INNV

Watchlist Manager
InnovAge Holding Corp Logo
InnovAge Holding Corp
NASDAQ:INNV
Watchlist
Price: 7.47 USD -3.98% Market Closed
Market Cap: $1B

InnovAge Holding Corp
Investor Relations

InnovAge Holding Corp. engages in the provision of a healthcare delivery platform. The company is headquartered in Denver, Colorado and currently employs 1,800 full-time employees. The company went IPO on 2021-03-04. The firm delivers its patient-centered care through the InnovAge Platform. InnovAge Platform is focused on frail, dual-eligible seniors, and it serve participants primarily through Program of All-inclusive Care for the Elderly (PACE). InnovAge Platform provides complete, coordinated healthcare to enable its frail, nursing home-eligible seniors to live independently in their homes and communities. The InnovAge Platform consists of Interdisciplinary Care Teams and community-based care delivery model. The firm's subsidiaries include TCO Intermediate Holdings, Inc., Total Community Options, Inc., InnovAge Investment Holdings, LLC, TCO Eastern Holdings, LLC, InnovAge Pennsylvania LIFE, LLC, InnovAge Virginia PACE Roanoke Valley, LLC, InnovAge Virginia PACE II, LLC, InnovAge Virginia PACE Charlottesville, LLC, Total Longterm Care Solutions, LLC, Total Longterm Care, Inc. and InnovAge Greater Colorado PACE-Loveland, LLC.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2026
Call Date
Feb 3, 2026
AI Summary
Q2 2026

Revenue Growth: InnovAge reported second quarter revenue of $239.7 million, up 14.7% year-over-year, driven by growth in member months and higher capitation rates.

Profitability Improvement: Adjusted EBITDA reached $22.2 million with a margin of 9.2% for the quarter, meeting the company’s intermediate-term target for the first time.

Guidance Raised: Full-year 2026 outlook was increased, with expected revenue of $925–950 million and adjusted EBITDA of $70–75 million.

Operational Progress: Strong results were attributed to improvements in Medicaid redeterminations, medical cost management, center efficiency, and SG&A discipline.

Regulatory Update: Management noted PACE’s partial insulation from Medicare rate changes due to the frailty adjuster and phase-in of the new risk adjustment model.

Census Growth: Participant census grew 7.1% year-over-year, with member months in the quarter up 7.9% year-over-year, exceeding expectations.

Key Financials
Revenue
$239.7 million
Adjusted EBITDA
$22.2 million
Net Income
$11.8 million
Net Income Per Share
$0.08
Adjusted EBITDA Margin
9.2%
Center-Level Contribution Margin
$52.8 million
Center-Level Contribution Margin Percentage
22%
External Provider Costs
$112 million
Cost of Care (excluding D&A)
$74.9 million
Sales and Marketing Expenses
$8.1 million
Corporate, General and Administrative Expenses
$26.6 million
Participants (Census)
8,010
Member Months
23,960
Cash and Cash Equivalents
$83.2 million
Short-Term Investments
$42.8 million
Total Debt
$69.9 million
Cash Flow from Operations
$21.4 million
Capital Expenditure
$2.4 million
De Novo Center Losses
$4.7 million
Other Earnings Calls

Management

Mr. Patrick Blair
Chief Executive Officer
No Bio Available
Mr. Benjamin Crowninshield Adams
Chief Financial Officer
No Bio Available
Ms. Nicole D'Amato
Chief Legal Officer & Corporate Secretary
No Bio Available
Hon. Marilyn Barbour Tavenner M.H.A., R.N.
Independent Director
No Bio Available
Mr. Michael Scarbrough
President & COO
No Bio Available
Ms. Cara Babachicos
Chief Information Officer
No Bio Available
Mr. Ryan Kubota
Director of Investor Relations
No Bio Available
Ms. Olivia Patton
Chief Compliance Officer
No Bio Available
Mr. Matt Huray
Chief Strategy & Corporate Development Officer
No Bio Available

Contacts

Address
COLORADO
Denver
8950 E. Lowry Boulevard
Contacts
+13038694664.0
www.innovage.com